Diabetic wound healing in a MMP9-/- mouse model

Wound Repair and Regeneration

Volumn 24, Issue 5, 2016, Pages 829-840

  Cho, Hongkwan ^a   Balaji, Swathi ^a,b   Hone, Natalie L ^a   Moles, Chad M ^b   Sheikh, Abdul Q ^a   Crombleholme, Timothy M ^c   Keswani, Sundeep G ^b   Narmoneva, Daria A ^a  

^a 705 Engineering Research Center   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; SILICONE; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; EXCISION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GRANULATION TISSUE; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MMP9 MOUSE; MORPHOLOGY; MOUSE; MOUSE MODEL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SPLINT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VASCULARIZATION; WILD TYPE; WOUND CLOSURE; WOUND CONTRACTION; WOUND HEALING;

EID: 84988948930     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12453     Document Type: Article

References (59)

1. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003; 26: 1790–5.
2. American Diabetes Association., Available from http://www.diabetes.org/diabetes-basic/statistics, 2011.
3. Liu ZJ, Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008; 10: 1869–82.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–7.
5. Zammaretti P, Zisch AH. Adult ‘endothelial progenitor cells’. Renewing vasculature. Int J Biochem Cell Biol 2005; 37: 493–503.
6. Young PP, Vaughan DE, Hatzopoulos AK. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007; 49: 421–9.
7. Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, Isner JM, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002; 30: 967–72.
8. Capla JM, Grogan RH, Callaghan MJ, Galiano RD, Tepper OM, Ceradini DJ, et al. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 2007; 119: 59–70.
9. Chen MC, Sheu JJ, Wang PW, Chen CY, Kuo MC, Hsieh CJ, et al. Complications impaired endothelial progenitor cell function in type 2 diabetic patients with or without critical leg ischaemia: implication for impaired neovascularization in diabetes. Diab Med 2009; 26: 134–41.
10. Kang L, Chen Q, Wang L, Gao L, Meng K, Chen J, et al. Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin Exp Pharmacol Physiol 2009; 36: e47–e56.
11. Westerweel PE, Teraa M, Rafii S, Jaspers JE, White IA, Hooper AT, et al. Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. PLoS One 2013; 8: e60357
12. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am CollCardiol 2005; 45: 1449–57.
13. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195–9.
14. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422–7.
15. Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 2008; 18: 33–7.
16. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Investig 2000; 106: 571–8.
17. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732–8.
18. Thom SR, Hampton M, Troiano MA, Mirza Z, Malay DS, Shannon S, et al. Measurements of CD34+/CD45-dim stem cells predict healing of diabetic neuropathic wounds. Diabetes 2016; 65: 486–97.
19. Feng G, Hao D, Chai J. Processing of CXCL12 impedes the recruitment of endothelial progenitor cells in diabetic wound healing. FEBS J 2014; 281: 5054–62.
20. Balaji S, Han N, Moles C, Shaaban AF, Bollyky PL, Crombleholme TM, et al. Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds. Surgery 2015; 158: 846–56.
21. Balaji S, King A, Crombleholme TM, Keswani SG. The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing. Adv Wound Care (New Rochelle) 2013; 2: 283–95.
22. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005; 45: 321–5.
23. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625–37.
24. Nakamura Y, Tajima F, Ishiga K, Yamazaki H, Oshimura M, Shiota G, et al. Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Exp Hematol 2004; 32: 390–6.
25. Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009; 29: 1179–84.
26. Lennartsson J, Ronnstrand L. Stem cell factor receptor/c-kit: from basic science to clinical implications. Physiol Rev 2012; 92: 1619–49.
27. Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 2004; 279: 18600–07.
28. Litz J, Krystal GW. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. Mol Cancer Ther 2006; 5: 1415–22.
29. Jin K, Mao XO, Sun Y, Xie L, Greenberg DA. Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest 2002; 110: 311–9.
30. Lutz M, Rosenberg M, Kiessling F, Eckstein V, Heger T, Krebs J, et al. Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells. Cardiovasc Res 2008; 77: 143–50.
31. Kim KL, Meng Y, Kim JY, Baek EJ, Suh W. Direct and differential effects of stem cell factor on the neovascularization activity of endothelial progenitor cells. Cardiovasc Res 2011; 92: 132–40.
32. Zgheib C, Xu J, Mallette AC, Caskey RC, Zhang L, Hu J, et al. SCF increases in utero-labeled stem cells migration and improves wound healing. Wound Repair Regen 2015; 23: 583–90.
33. Aye MT, Hashemi S, Leclair B, Zeibdawi A, Trudel E, Halpenny M, et al. Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp Hematol 1992; 20: 523–7.
34. Dentelli P, Rosso A, Balsamo A, Colmenares Benedetto S, Zeoli A, Pegoraro M, et al. C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 2007; 109: 4264–71.
35. Bischoff SC, Sellge G, Manns MP, Lorentz A. Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells. Int Arch Allergy and Immunol 2001; 124: 151–4.
36. Janeway C. Immunobiology: the immune system in health and disease, 4th ed. London, New York, NY, US: Current Biology Publications; Garland Pub., 1999.
37. Cho H, Balaji S, Sheikh AQ, Hurley JR, Tian YF, Collier JH, et al. Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers. Acta Biomater 2012; 8: 154–64.
38. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004; 12: 485–92.
39. Balaji S, Vaikunth SS, Lang SA, Sheikh AQ, Lim FY, Crombleholme TM, et al. Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing. Wound Repair Regen 2012; 20: 15–27.
40. Morris LM, Klanke CA, Lang SA, Pokall S, Maldonado AR, Vuletin JF, et al. Characterization of endothelial progenitor cells mobilization following cutaneous wounding. Wound Repair Regen 2010; 18: 383–90.
41. Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Investig Dermatol 1998; 111: 850–7.
42. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007; 117: 1249–59.
43. Tepper OM, Carr J, Allen RJ, Jr., Chang CC, Lin CD, Tanaka R, et al. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 2010; 59: 1974–83.
44. Reber L, Da Silva CA, Frossard N. Stem cell factor and its receptor c-kit as targets for inflammatory diseases. Eur J Pharmacol 2006; 533: 327–40.
45. Nucera S, Biziato D, De Palma M. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int J Dev Biol 2011; 55: 495–503.
46. Newman AC, Hughes CC. Macrophages and angiogenesis: a role for wnt signaling. Vasc Cell 2012; 4: 13
47. Suh W, Kim KL, Kim JM, Shin IS, Lee YS, Lee JY, et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005; 23: 1571–8.
48. Fukuda S, Nagano M, Yamashita T, Kimura K, Tsuboi I, Salazar G, et al. Functional endothelial progenitor cells selectively recruit neurovascular protective monocyte-derived F4/80(+)/Ly6c(+) macrophages in a mouse model of retinal degeneration. Stem Cells 2013; 31: 2149–61.
49. Thom SR, Milovanova TN, Yang M, Bhopale VM, Sorokina EM, Uzun G, et al. Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy. Wound Repair Regen 2011; 19: 149–61.
50. Galli SJ, Iemura A, Garlick DS, Gamba-Vitalo C, Zsebo KM, Andrews RG. Reversible expansion of primate mast cell populations in vivo by stem cell factor. J Clin Invest 1993; 91: 148–52.
51. Jordan JH, Schernthaner GH, Fritsche-Polanz R, Sperr WR, Fodinger M, Chott A, et al. Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria. Leuk Lymphoma 2002; 43: 575–82.
52. Ando A, Martin TR, Galli SJ. Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient sl/sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. J Clin Invest 1993; 92: 1639–49.
53. Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR, et al. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 2005; 11: 206–13.
54. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008; 197: 496–503.
55. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, et al. Db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007; 15: 665–70.
56. Kyriakides TR, Wulsin D, Skokos EA, Fleckman P, Pirrone A, Shipley JM, et al. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol 2009; 28: 65–73.
57. Tang J, Liu J, Zhou C, Alexander JS, Nanda A, Granger DN, et al. Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab 2004; 24: 1133–45.
58. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000; 106: 55–62.
59. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110: 625–32.